AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $413,000 | -29.6% | 700,000 | -35.6% | 0.06% | -24.1% |
| Q4 2016 | $587,000 | -39.4% | 1,087,715 | 0.0% | 0.08% | -26.2% |
| Q3 2016 | $968,000 | -7.4% | 1,087,715 | 0.0% | 0.11% | -27.7% |
| Q2 2016 | $1,045,000 | +4.4% | 1,087,715 | 0.0% | 0.15% | -2.0% |
| Q1 2016 | $1,001,000 | -27.0% | 1,087,715 | 0.0% | 0.15% | -7.9% |
| Q4 2015 | $1,371,000 | -28.6% | 1,087,715 | -31.5% | 0.16% | -46.6% |
| Q3 2015 | $1,921,000 | -30.5% | 1,587,715 | 0.0% | 0.31% | -16.3% |
| Q2 2015 | $2,763,000 | – | 1,587,715 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |